Figure 2.
Cytoreductive discontinuation rates. Annual discontinuation rates in patients receiving rIFN-α (top panel) and HU (bottom panel).

Cytoreductive discontinuation rates. Annual discontinuation rates in patients receiving rIFN-α (top panel) and HU (bottom panel).

Close Modal

or Create an Account

Close Modal
Close Modal